Ensign Peak Advisors, Inc
Position in ARQT — Arcutis Biotherapeutics, Inc.
CIK 1454984
SALT LAKE CITY, UT
Position in ARQT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$25,552,281
-$3,765,476 QoQ
Shares Held
974,534
-21.7% QoQ
Ownership
0.775%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#32
of 271 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARQT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ensign Peak Advisors, Inc holds $1,119,129,230 across 124 Biotechnology names. ARQT ranks #13 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
210,483 | $104,553,220 | |
| 2 | INSM |
INSMED Inc
|
702,951 | $74,948,635 | |
| 3 | ABVX |
Abivax S.A.
|
504,471 | $67,225,805 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
760,977 | $56,677,566 | |
| 5 | ARGX |
Argenx SE
|
52,027 | $48,269,089 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
508,056 | $41,442,127 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
591,815 | $33,621,010 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
579,052 | $31,847,860 |
All Filings in ARQT
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,552,281 | 974,534 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $29,317,757 | 1,244,387 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $55,245,405 | 1,902,390 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $37,569,086 | 1,993,055 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $28,060,174 | 2,001,439 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $31,098,403 | 1,988,389 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $33,071,770 | 2,374,140 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $22,476,351 | 2,416,812 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $19,843,428 | 2,133,702 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $29,535,238 | 2,980,347 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $6,556,761 | 2,029,957 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,386,564 | 826,095 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $7,934,106 | 832,540 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $5,348,640 | 486,240 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $7,171,369 | 484,552 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $9,351,382 | 489,345 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,095,562 | 379,895 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $9,542,367 | 495,450 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $8,704,038 | 419,674 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $9,315,618 | 389,938 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $10,840,024 | 397,216 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $4,952,902 | 171,203 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $1,085,930 | 38,604 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $640,966 | 21,876 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $226,800 | 7,500 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $223,500 | 7,500 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||